Jeff
Berkowitz
Independent Non-Executive Director
Jeff joined the Board on 18 September 2020. Jeff has extensive global healthcare experience, having held senior executive positions at UnitedHealth Group/Optum, Walgreens Boots Alliance Inc. and Merck & Co Inc. Jeff is CEO of Real Endpoints LLC, a leader in providing insights, support and tools to strengthen access to pharmaceutical innovation for an evolving healthcare landscape. He also serves on the board of directors of H. Lundbeck A/S, Esperion Therapeutics, Inc., and Zealand Pharmaceuticals, Inc.